ID
26125
Beskrivning
Study ID: 111029 Clinical Study ID: 111029 Study Title: Double-blind, randomized study to evaluate the immunogenicity and reactogenicity of three different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 6 month schedule in healthy adult subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00289757 https://clinicaltrials.gov/ct2/show/NCT00289757 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis A Vaccine, Inactivated Trade Name: Havrix Study Indication: Hepatitis A Documentation part: Post Vaccination (Additional Vaccination after Visit 22)
Länk
https://clinicaltrials.gov/ct2/show/NCT00289757
Nyckelord
Versioner (1)
- 2017-10-09 2017-10-09 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
9 oktober 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine Post Vaccination 111029
Post Vaccination Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine 111029
Beskrivning
Post Vaccination
Alias
- UMLS CUI-1
- C1443955
- UMLS CUI-2
- C0042196
- UMLS CUI-3
- C0700881
Similar models
Post Vaccination Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine 111029
C0042196 (UMLS CUI-2)
C0700881 (UMLS CUI-3)
C0042196 (UMLS CUI-2)
C0700881 (UMLS CUI-3)
C0005834 (UMLS CUI [1,2])